Skip to main content
. 2022 Jan 4;11:799082. doi: 10.3389/fonc.2021.799082

Figure 2.

Figure 2

LncRNA KRT19P3 inhibited BC growth in vivo. (A) A stable MDA-MB-231 cell line overexpressing KRT19P3(LV-KRT19P3) was constructed and injected under the subcutaneous of nude mice to establish a xenograft tumor model with 6 mice in each group. Moreover, primary tumor growth was measured every week after injection. The tumor volumes in the LV-KRT19P3 group were significantly smaller than those in the LV-NC group. (B) Immunohistochemistry for Ki-67 detection revealed that cancer cells in the LV-NC group showed a higher positivity rate than those in the LV-KRT19P3 group (magnification × 200).